Literature DB >> 1233213

Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects.

L F Chasseaud, W H Down, R K Grundy.   

Abstract

An oral dose of 5 mg of 14C-isosorbide dinitrate was rapidly absorbed, biotransformed and excreted by human subjects. Peak whole blood concentrations of radioactivity were reached after 1.5 to 2 hours and declined relatively slowly. The radioactivity in whole blood mainly represented metabolites, isosorbide mononitrates. The peak concentrations found were 4.5, 11.7 and 34.3 ng/ml of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrate, respectively, in the blood of one subject and 5.9, 15 and 61.3 ng/ml, respectively, in the blood of another subject. However, concentrations of the metabolites declined relatively slowly during 6 h after the oral urine of the first day (ca. 78%). The results showed that isosorbide mononitrates were available to contribute to the pharmacological action.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233213     DOI: 10.1007/bf00567108

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Comparative responses to various nitrates in the treatment of angina pectoris.

Authors:  H I RUSSEK; E H FUNK
Journal:  Postgrad Med       Date:  1962-02       Impact factor: 3.840

Review 2.  The nature and distribution of enzymes catalyzing the conjugation of glutathione with foreign compounds.

Authors:  L F Chasseaud
Journal:  Drug Metab Rev       Date:  1973       Impact factor: 4.518

3.  The metabolic fate of bentazon in the rat.

Authors:  L F Chasseaud; D R Hawkins; B D Cameron; B J Fry; V H Saggers
Journal:  Xenobiotica       Date:  1972-05       Impact factor: 1.908

4.  The therapeutic role of coronary vasodilators: glyceryl trinitrate, isosorbide dinitrate, and pentaerythritol tetranitrate.

Authors:  H I Russek
Journal:  Am J Med Sci       Date:  1966-07       Impact factor: 2.378

5.  Clearance and metabolism of organic nitrates.

Authors:  E M Johnson; A B Harkey; D J Blehm; P Needleman
Journal:  J Pharmacol Exp Ther       Date:  1972-07       Impact factor: 4.030

6.  Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide.

Authors:  R L Wendt
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

7.  Organic nitrates: relationship between biotransformation and rational angina pectoris therapy.

Authors:  P Needleman; S Lang; E M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

Review 8.  Aspects of nitrate ester metabolism.

Authors:  M H Litchfield
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

9.  Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin.

Authors:  R E Goldstein; D R Rosing; D R Redwood; G D Beiser; S E Epstein
Journal:  Circulation       Date:  1971-05       Impact factor: 29.690

10.  Vascular effects of the dinitrate and moninitrate esters of isosorbide, isomannide and isoidide.

Authors:  M G Bogaert; M T Rosseel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

View more
  8 in total

1.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

2.  Kinetics of isosorbide dinitrate and relationships to pharmacological effects.

Authors:  H L Fung; E F McNiff; D Ruggirello; A Darke; U Thadani; J O Parker
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

3.  Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate.

Authors:  M Meffert; I M Paeckelmann
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Fate of isosorbide dinitrate and mononitrates in patients with renal failure.

Authors:  M G Bogaert; M T Rosseel; J Boelaert; R Daneels
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man.

Authors:  S J Shane; J J Iazzetta; A W Chisholm; J F Berka; D Leung
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

6.  Effects and pharmacokinetics of isosorbide dinitrate in normal man.

Authors:  S Spörl-Radun; G Betzien; B Kaufmann; V Liede; U Abshagen
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

7.  Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.

Authors:  U Abshagen; G Betzien; R Endele; B Kaufmann; G Neugebauer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Pharmacokinetics of intravenous isosorbide-dinitrate.

Authors:  R Platzer; G Reutemann; R L Galeazzi
Journal:  J Pharmacokinet Biopharm       Date:  1982-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.